Literature DB >> 26066595

The Influence of Coping on Vision-Related Quality of Life in Patients With Low Vision: A Prospective Longitudinal Study.

Bonnie A Sturrock1, Jing Xie1, Edith E Holloway1, Ecosse L Lamoureux2, Jill E Keeffe3, Eva K Fenwick1, Gwyneth Rees1.   

Abstract

PURPOSE: To determine the longitudinal impact of specific coping strategies on vision-related quality of life (VRQoL) in patients with low vision.
METHODS: This was a single-group, longitudinal study utilizing telephone-administered interviews conducted at baseline and at 3 and 6 months with patients (visual acuity < 6/12 in the better eye) recruited from low vision services. The Coping Strategy Indicator (CSI) assessed three strategies used specifically in relation to vision-related problems: avoidant coping, problem-solving coping, and seeking social support. Vision-related quality of life was assessed using the Impact of Vision Impairment (IVI) questionnaire, which comprises two domains: vision-related functioning and vision-related emotional well-being. We used multivariable mixed linear regression including time as an independent variable to assess change in VRQoL.
RESULTS: The study comprised 162 patients (mean age = 69.8 years, 66% female), most with age-related macular degeneration (42%) and moderate vision impairment (41%; <6/18-6/60). Multivariable mixed linear regression showed that avoidant coping was a significant determinant of decline in vision-related functioning (β = -0.11, 95% confidence interval [CI] -0.22 to -0.01, P = 0.036) and emotional well-being (β = -0.29, 95% CI -0.45 to -0.13, P < 0.001) over a 6-month period.
CONCLUSIONS: Our findings showed that avoidant coping has a detrimental impact on VRQoL over time. Low vision specialists should be aware of their patients' coping strategies and encourage them to engage in active rather than avoidant coping to deal with the impact of their vision impairment.

Entities:  

Mesh:

Year:  2015        PMID: 26066595     DOI: 10.1167/iovs.14-16223

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Domains of health-related quality of life in age-related macular degeneration: a qualitative study in the Chinese cultural context.

Authors:  Wei Bian; Junli Wan; Graeme Smith; Shiying Li; Mingqiong Tan; Fengjiao Zhou
Journal:  BMJ Open       Date:  2018-04-17       Impact factor: 2.692

2.  Coping strategy in persons with low vision or blindness - an exploratory study.

Authors:  Puja Rai; Jolly Rohatgi; Upreet Dhaliwal
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848

3.  Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment.

Authors:  Jian-Yu E; Tianjing Li; Lianne McInally; Katie Thomson; Uma Shahani; Lyle Gray; Tracey E Howe; Dawn A Skelton
Journal:  Cochrane Database Syst Rev       Date:  2020-09-03

4.  Coping strategies, vision-related quality of life, and emotional health in managing retinitis pigmentosa: a survey study.

Authors:  Krithika Anil; Gulcan Garip
Journal:  BMC Ophthalmol       Date:  2018-01-30       Impact factor: 2.209

5.  Predictors of health-related quality of life in Chinese patients receiving treatment for neovascular age-related macular degeneration: a prospective longitudinal study.

Authors:  Wei Bian; Junli Wan; Mingqiong Tan; Jun Su; Yi Yuan; Zonghua Wang; Shiying Li
Journal:  BMC Ophthalmol       Date:  2020-07-16       Impact factor: 2.209

6.  Mastery and self-esteem mediate the association between visual acuity and mental health: a population-based longitudinal cohort study.

Authors:  I M Maaswinkel; H P A van der Aa; G H M B van Rens; A T F Beekman; J W R Twisk; R M A van Nispen
Journal:  BMC Psychiatry       Date:  2020-09-24       Impact factor: 3.630

7.  Barriers and facilitators to recognize and discuss depression and anxiety experienced by adults with vision impairment or blindness: a qualitative study.

Authors:  Edine P J van Munster; Hilde P A van der Aa; Peter Verstraten; Ruth M A van Nispen
Journal:  BMC Health Serv Res       Date:  2021-07-28       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.